Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mecamylamine in diabetic macular edema
NCT00536692Phase 2Completed
- Sponsor
- CoMentis, Inc.
- Start
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nicotine + mecamylamine in diabetic macular edema (DME), sponsored by CoMentis, Inc.. Started Sep 2007; status: completed.
02
Drugs
nicotine + mecamylamine
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT00536692.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00536692.